图片搜索

   粘贴图片网址
IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. Silvia1,2,3; Poirel, Laurent4,5; Bonomo, Robert A.6,7,8; Schwaber, Mitchell J.9; Daikos, George L.10; Cormican, Martin11; Cornaglia, Giuseppe12; Garau, Javier13; Gniadkowski, Marek14; Hayden, Mary K.15,16; Kumarasamy, Karthikeyan17; Livermore, David M.18,19; Maya, Juan J.20; Nordmann, Patrice4,5; Patel, Jean B.21; Paterson, David L.22; Pitout, Johann23,24; Villegas, Maria Virginia20; Wang, Hui25; Woodford, Neil19; Quinn, John P.26
刊名LANCET INFECTIOUS DISEASES
2013-09-01
DOI10.1016/S1473-3099(13)70190-7
13期:9页:785-796
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Infectious Diseases
研究领域[WOS]Infectious Diseases
关键词[WOS]HYDROLYZING BETA-LACTAMASE ; KPC-PRODUCING ENTEROBACTERIACEAE ; GRAM-NEGATIVE BACILLI ; ACUTE-CARE FACILITIES ; NEW-YORK-CITY ; ESCHERICHIA-COLI ; PSEUDOMONAS-AERUGINOSA ; RESISTANT ENTEROBACTERIACEAE ; K.-PNEUMONIAE ; UNITED-STATES
英文摘要

Klebsiella pneumoniae carbapenemases (KPCs) were originally identified in the USA in 1996. Since then, these versatile beta-lactamases have spread internationally among Gram-negative bacteria, especially K pneumoniae, although their precise epidemiology is diverse across countries and regions. The mortality described among patients infected with organisms positive for KPC is high, perhaps as a result of the limited antibiotic options remaining (often colistin, tigecycline, or aminoglycosides). Triple drug combinations using colistin, tigecycline, and imipenem have recently been associated with improved survival among patients with bacteraemia. In this Review, we summarise the epidemiology of KPCs across continents, and discuss issues around detection, present antibiotic options and those in development, treatment outcome and mortality, and infection control. In view of the limitations of present treatments and the paucity of new drugs in the pipeline, infection control must be our primary defence for now.

语种英语
WOS记录号WOS:000323465900024
资助机构Sage and Steris ; Merck ; grant Narodowy Program Ochrony Antybiotykow (NPOA) from the Polish Ministry of Health ; grant SPUB MIKROBANK from the Polish Ministry of Science and Higher Education ; Pfizer ; Novartis ; AstraZeneca ; Astellas ; Merck Sharp Dohme ; Pfizer SA ; Janssen-Cilag SA ; Merck Colombia ; AstraZeneca Colombia SA ; bioMerieux Colombia SAS ; Colciencias
引用统计
被引频次:505[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56633
专题北京大学第二临床医学院
作者单位1.Univ Miami, Miller Sch Med, Dept Med, Dept Publ Hlth Sci, Miami, FL 33136 USA
2.Univ Miami, Miller Sch Med, Dept Anesthesiol, Miami, FL 33136 USA
3.Jackson Mem Hosp, Dept Infect Control, Miami, FL 33136 USA
4.Hop Bicetre, AP HP, Serv Bacteriol Virol, INSERM Emerging Resistance Antibiot U914,Fac Med, K Bicetre, France
5.Univ Paris Sud, K Bicetre, France
6.Louis Stokes Cleveland Dept Vet Affairs, Res Serv, Cleveland, OH USA
7.Case Western Reserve Univ, Dept Med Pharmacol, Dept Mol Biol, Cleveland, OH 44106 USA
8.Case Western Reserve Univ, Dept Microbiol, Cleveland, OH 44106 USA
9.Israel Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel
10.Univ Athens, Sch Med, Dept Propaedeut Med, GR-11527 Athens, Greece
11.Natl Univ Ireland Galway, Sch Med, Antimicrobial Resistance & Microbial Ecol ARME Gr, Galway, Ireland
12.Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy
13.Univ Barcelona, Infect Dis Unit, Hosp Univ Mutua Terrassa, Barcelona, Spain
14.Natl Med Inst, Dept Mol Microbiol, Warsaw, Poland
15.Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA
16.Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA
17.Univ Madras, Dept Microbiol, Dr ALM PG IBMS, Madras, Tamil Nadu, India
18.Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England
19.Publ Hlth England, Antimicrobial Resistance & Healthcare Assoc Infec, London, England
20.Int Ctr Med Res andTraining CIDEIM, Cali, Colombia
21.Ctr Dis Control & Prevent, Atlanta, GA USA
22.Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Herston, Qld, Australia
23.Calgary Lab Serv, Div Microbiol, Calgary, AB, Canada
24.Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
25.AstraZeneca, Waltham, MA USA
26.Peking Univ Peoples Hosp, Dept Clin Lab, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Munoz-Price, L. Silvia,Poirel, Laurent,Bonomo, Robert A.,et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases[J]. LANCET INFECTIOUS DISEASES,2013,13(9):785-796.
APA Munoz-Price, L. Silvia.,Poirel, Laurent.,Bonomo, Robert A..,Schwaber, Mitchell J..,Daikos, George L..,...&Quinn, John P..(2013).Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.LANCET INFECTIOUS DISEASES,13(9),785-796.
MLA Munoz-Price, L. Silvia,et al."Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases".LANCET INFECTIOUS DISEASES 13.9(2013):785-796.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Munoz-Price, L. Silvia]的文章
[Poirel, Laurent]的文章
[Bonomo, Robert A.]的文章
百度学术
百度学术中相似的文章
[Munoz-Price, L. Silvia]的文章
[Poirel, Laurent]的文章
[Bonomo, Robert A.]的文章
必应学术
必应学术中相似的文章
[Munoz-Price, L. Silvia]的文章
[Poirel, Laurent]的文章
[Bonomo, Robert A.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。